Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece

Epidemiology and Infection

Volumn 135, Issue 6, 2007, Pages 943-950

  Kroupis, C ^a   Thomopoulou, G ^b   Papathomas, Thomas G ^a,c   Vourlidis, N ^b   Lazaris, A C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b 'Mitera' Maternity and Surgical Center   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GREECE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; WOMEN'S HEALTH; CLASSIFICATION; GENETICS; HEALTH SURVEY; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADOLESCENT; ADULT; AGED; FEMALE; GREECE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34748876509     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880700876X     Document Type: Article

References (40)

1. Parkin DM, et al. Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 2001; 94: 153-156.
2. National Cancer Institute. SEER Cancer Statistics Review, 1975-2003 database (http://www.seer.cancer.gov/csr/1975_2003/). Accessed 10 September 2006.
3. Bergeron C. What have we learned and what is still unclear in HPV infections and preinvasive disease? In: 20th European Congress of Pathology: Update in Pathology, 2005. Paris: European Society of Pathology, 2005, pp. 179-180.
4. Burd EM. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews 2003; 16: 1-17.
5. Muñoz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine 2003; 348, 518-527.
6. Gillison ML, Shah KV. Role of mucosal human papillomavirus in nongenital cancers. Journal of the National Cancer Institute Monograph 2003; 9: 57-65.
7. Evander M, et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a populatioh-based study of human papillomavirus infection in young Swedish women. Journal of Clinical Microbiology 1992; 30: 987-992.
8. Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 1999; 189: 12-19.
9. Greer CE, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. Journal of Clinical Microbiology 1995; 33: 2059-2063.
10. Giuliano AR, et al. Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and control. Cancer Epidemiology Biomarkers & Prevention 2001; 10: 1129-1136.
11. Muñoz N, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer 2004; 111: 278-285.
12. Bauer HM, Manos NM. PCR detection of human genital papillomavirus. In: Persing DH, ed. Diagnostic Molecular Microbiology: Principles and Applications. Washington, DC: ASM Press, 1993, pp. 407-413.
13. Hildesheim A, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. Journal of Infectious Diseases 1994; 169: 235-240.
14. de Roda Husman AM, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. Journal of General Virology 1995; 76: 1057-1062.
15. Labropoulou V, et al. Type-specific prevalence of genital human papillomaviruses in benign, premalignant, and malignant biopsies in patients from Greece. Sexually Transmitted Diseases 1997; 24 469-474.
16. Kroupis C, et al. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clinical Biochemistry 2006; 39: 727-731.
17. Bernard HU, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. Journal of Infectious Diseases 1994; 170: 1077-1085.
18. Sherman ME, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. Journal of the National Cancer Institute 2003; 95: 46-52.
19. Woodman CB, et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001; 357: 1831-1836.
20. Rozendaal L, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. International Journal of Cancer 1996; 68: 766-769.
21. Castle PE, et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus, DNA-positive, cytologically negative women. Cancer 2002; 95: 2145-2151.
22. Manos NM et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Journal of the American Medical Association 1999; 281 1605-1610.
23. Schleck NF, et al. Human papillomavirus infection and time to progression and regression of cervical intra-epithelial neoplasia. Journal of the National Cancer Institute 2003; 95: 1336-1343.
24. Herrero R, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. Journal of the National Cancer Institute 2000; 92: 464-474.
25. Rader AE, et al. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytologica 1999; 43: 357-362.
26. Lawson HW, et al. Cervical cancer screening among low-income women: Results of a national screening program, 1991-1995. Obstetrics and Gynecology 1998; 92: 745-752.
27. Keating JT, Wang HH. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and post-menopausal women. Cancer 2001; 93: 100-105.
28. Lousuebsakul V, et al. Variables associated with squamous intraepithelial lesions among women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Analytical and Quanttative Cytology and Histology 2001; 23: 355-361.
29. Burk RD, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sexually Transmitted Diseases 1996; 23: 333-341.
30. Syrjänen S, et al. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the new independent states of the Former Soviet Union. Journal of Clinical Microbiology 2004; 42: 505-511.
31. Kaufman RH, et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. American Journal of Obstetrics and Gynecology 1997; 176: 87-92.
32. Herrero R, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. Journal of Infectious Diseases 2005; 191: 1796-1807.
33. Hwang HS, et al. Distribiition and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA Chip. Cancer Epidemiology Biomarkers Prevention 2004; 13: 2153-2156.
34. Swan DC, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. Journal of Clinical Microbiology 4999; 37: 1030-1034.
35. Cavalcanti SM, et al. Human papillomavirus infection and cervical cancer in Brazil: A retrospective study. Memórias do Instituto Oswaldo Cruz 1996; 91: 433-440.
36. Ho GY, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intraepithelial neoplasia. International Journal of Cancer 1998; 78: 281-285.
37. Lee GY, et al. Human papillomavirus (HPV) geno-typing by HPV DNA chip in cervical cancer and precancerous lesions. International Journal of Gynecological Cancer. 2005; 15: 81-87.
38. Chan PK, et al. Association of human papillomavirus type 58 variant with the risk of tervical cancer. Journal of the National Cancer Institute 2002; 94: 1249-1253.
39. Gonzalez-Losa M, et al. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. Journal of Clinical Virology 2004; 29: 202-205.
40. Agorastos T, et al. Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece. European Journal of Cancer Prevention 2004; 13: 145-147.